Structures of a Na+-coupled, substrate-bound MATE multidrug transporter

By Min Lu, Jindrich Symersky, Martha Radchenko, Akiko Koide, Yi Guo, Rongxin Nie, and Shohei Koide.

Published in Proceedings of the National Academy of Sciences of the United States of America 110(6): 2099-104 (2013) on January 22, 2013. PMID: 22143771. PMCID: PMC3251152. Link to Pubmed page.

Core Facility: Synthetic Antigen Binder (SAB) Generation and Crystallography

Figure 1. Structure of NorM-NG-monobody complex. (A and B) Structure of NorM-NG monobody complex as viewed from the membrane plane. The views in A and B are related by ∼180° rotation around the membrane normal. The amino (residues 5–230) and carboxyl (residues 231–459) halves of NorM-NG are colored cyan and yellow, respectively. Monobody is shown as a magenta ribbon and bound TPP as magenta sticks. (C) The arrangement of transmembrane helices in NorM-NG as viewed from the periplasmic side. (D) NorM-NG surface as viewed from the periplasmic side, which is colored according to electrostatic potentials from −20 (red) to +20 kTe−1 (blue).


Advanced free energy perturbation molecular dynamics (FEP/MD) simulation methods are available to accurately calculate absolute binding free energies of protein-ligand complexes. However, these methods rely on several sophisticated command scripts implementing various biasing energy restraints to enhance the convergence of the FEP/MD calculations, which must all be handled properly to yield correct results. Here, we present a user-friendly Web interface, CHARMM-GUI Ligand Binder ( ), to provide standardized CHARMM input files for calculations of absolute binding free energies using the FEP/MD simulations. A number of features are implemented to conveniently set up the FEP/MD simulations in highly customizable manners, thereby permitting an accelerated throughput of this important class of computations while decreasing the possibility of human errors. The interface and a series of input files generated by the interface are tested with illustrative calculations of absolute binding free energies of three nonpolar aromatic ligands to the L99A mutant of T4 lysozyme and three FK506-related ligands to FKBP12. Statistical errors within individual calculations are found to be small (∼1 kcal/mol), and the calculated binding free energies generally agree well with the experimental measurements and the previous computational studies (within ∼2 kcal/mol). Therefore, CHARMM-GUI Ligand Binder provides a convenient and reliable way to set up the ligand binding free energy calculations and can be applicable to pharmaceutically important protein-ligand systems.


Figure 2. Structure of the multidrug-binding site.

Figure 3.Na+-induced protein conformational changes.

Figure 4. Proposed antiport mechanism.